BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18803735)

  • 1. Risk profiles for non-adherence to antipsychotic medications.
    McCann TV; Boardman G; Clark E; Lu S
    J Psychiatr Ment Health Nurs; 2008 Oct; 15(8):622-9. PubMed ID: 18803735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of antipsychotic medication taking in people with schizophrenia.
    McCann TV; Deans C; Clark E; Lu S
    Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessing health care professionals about antipsychotic medication related concerns.
    Boardman GH; McCann TV; Clark E
    Issues Ment Health Nurs; 2008 Jul; 29(7):739-54. PubMed ID: 18592424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia.
    Rungruangsiripan M; Sitthimongkol Y; Maneesriwongul W; Talley S; Vorapongsathorn T
    Arch Psychiatr Nurs; 2011 Aug; 25(4):269-83. PubMed ID: 21784285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence and significant others' support of consumers with schizophrenia in Australia.
    McCann TV; Lu S
    Nurs Health Sci; 2009 Sep; 11(3):228-34. PubMed ID: 19689630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.
    Novick D; Haro JM; Suarez D; Perez V; Dittmann RW; Haddad PM
    Psychiatry Res; 2010 Apr; 176(2-3):109-13. PubMed ID: 20185182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research.
    Kikkert MJ; Barbui C; Koeter MW; David AS; Leese M; Tansella M; Gieler A; Puschner B; Schene AH
    J Nerv Ment Dis; 2008 Apr; 196(4):274-81. PubMed ID: 18414121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
    Talam NC; Gatongi P; Rotich J; Kimaiyo S
    East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
    Misdrahi D; Verdoux H; Lançon C; Bayle F
    Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder.
    Quach PL; Mors O; Christensen TØ; Krarup G; Jørgensen P; Bertelsen M; Jeppesen P; Petersen L; Thorup A; Nordentoft M
    Early Interv Psychiatry; 2009 Feb; 3(1):66-74. PubMed ID: 21352177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novelty seeking and medication adherence in patients with schizophrenia.
    Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
    Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension--a primary care study.
    Maguire LK; Hughes CM; McElnay JC
    Patient Educ Couns; 2008 Nov; 73(2):371-6. PubMed ID: 18692978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication.
    Gray R; Rofail D; Allen J; Newey T
    J Adv Nurs; 2005 Oct; 52(1):31-7. PubMed ID: 16149978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence and nonadherence to antipsychotic medications.
    Kozuki Y; Schepp KG
    Issues Ment Health Nurs; 2005 May; 26(4):379-96. PubMed ID: 16020055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.